Senior Analyst (R&D Finance/Accounting)

Summit Therapeutics; Palo Alto (CA); On-site; USD 117,000 - 130,000; Full time

Job summary

Summit Therapeutics Inc. is a biopharmaceutical oncology company seeking a Senior Analyst (R&D Accounting & Finance) to ensure accurate financial operations and regulatory compliance.

The role reports to the Senior Manager of Finance and supports monthly closes, GAAP controls, and SOX compliance in a fast-paced environment. Responsibilities include reviewing CRO entries, managing trial accruals for Phase 2/3, and coordinating site payments against CTAs, while partnering with Clinical Operations

Qualifications

• Bachelor’s degree in finance, business, accounting or related field preferred
• CPA or progress toward designation preferred
• A minimum of 4+ years of experience in accounting
• Experience in the life sciences industry, with prior exposure to clinical study accruals strongly preferred
• Strong understanding of GAAP, internal controls, SOX controls and month-end close procedures required
• Must be proficient in handling large-scale financial data using Excel and financial systems for accurate analysis and reporting
• High level of accuracy and attention to detail
• Demonstratable experience of working within a fast-paced finance function
• Demonstratable experience of prioritizing workload and managing multiple tight deadlines effectively under pressure in a fast-paced environment
• Excellent communication skills with the ability to forge strong internal and external working relationships, and the confidence to challenge information constructively
• Enthusiastic team player with an approachable manner and an ability to engage with colleagues across the business with a constructive and can-do attitude to deliver the successful completion of team outputs within required deadlines.

Responsibilities

• Support the Sr. Manager, Finance with the monthly close process to ensure timely and accurate financial reporting, with a focus on continuous process improvement and reducing close timelines.
• Prepare and review high visibility CRO entries, Investigator Grant entries and other R&D entries, including those related to Phase 2 and Phase 3 clinical trials.
• Own and review the accounting and financial tracking for clinical trial accruals across multiple Phase 2 and Phase 3 trials, working closely with cross-functional teams to ensure the data is complete, accurate, and audit-compliant.
• Lead site payments process with 3rd party vendor clinical sites by reviewing and validating invoices against Clinical Trial Agreements (CTAs), working with the Clinical Operations and Study Start Up (SSU) teams and resolving any issues quickly and timely.
• Collaborate cross-functionally with other teams such as Clinical Operations and SSU to support strategic business objectives and ensuring the accuracy of financial information across Phase 2 and Phase 3 studies.
• Maintain and monitor SOX controls related to operational accounting are completed on time and are working as intended. Proactively identify and escape any control deficiencies.
• Assist with audit preparation by gathering needed documents, preparing schedules (PBCs), and responding to audit requests.
• All other duties as assigned.

Skills

Financial reporting

GAAP

SOX controls

Excel

Audit preparation

Month-end close

Cross-functional collaboration

Communication skills

Education

Bachelor’s degree in finance, accounting or related field

CPA or progress toward designation

Tools

ERP systems

Financial software

Job description

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.

HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.

HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Overview of Role:

Reporting to the Senior Manager of Finance, the Senior Analyst (R&D Accounting & Finance) role plays a keypartin ensuringaccuratefinancial operations and compliance across the company.

Role and Responsibilities:

• Support the Sr. Manager, Finance with the monthly close process to ensuretimelyandaccuratefinancial reporting, with a focus on continuous process improvement and reducing close timelines.
• Prepare and review high visibility CRO entries, Investigator Grant entries and other R&D entries, including those related to Phase 2 and Phase 3 clinical trials.
• Own and review the accounting and financial tracking for clinical trial accruals across multiple Phase 2 and Phase 3 trials, working closely with cross-functional teams to ensure the data is complete,accurate, and audit-compliant.
• Lead site payments process with 3 rd party vendor clinical sites by reviewing and validating invoices against Clinical Trial Agreements (CTAs), working with the Clinical Operations and Study Start Up (SSU) teams and resolving any issues quickly andtimely.
• Collaborate cross-functionally with other teams such as Clinical Operations and,SSU tosupport strategic businessobjectivesandensuringthe accuracy of financial information across Phase 2 and Phase 3 studies.
• Maintain and monitor SOX controls related to operational accounting are completed on time and are working as intended. Proactivelyidentifyand escape any control deficiencies.
• Assistwith audit preparation by gathering needed documents, preparing schedules (PBCs), and responding to audit requests.
• All other duties as assigned.

Experience, Education and Specialized Knowledge and Skills:

• Bachelor’s degree in finance, business,accountingor related field preferred
• CPA or progress toward designation preferred
• A minimum of 4+ years of experience in accounting
• Experience in the life sciences industry, with prior exposure to clinical study accruals strongly preferred
• Strong understanding of GAAP, internal controls, SOXcontrolsand month-end close proceduresrequired
• Must be proficient in handling large-scale financial data using Excel and financial systems foraccurateanalysis and reporting
• High levelof accuracy and attention to detail
• Demonstratable experience of working within a fast-paced finance function
• Demonstratable experience of prioritizing workload and managing multiple tight deadlines effectively under pressure in a fast-paced environment
• Excellent communication skills with the ability to forge strong internal and external working relationships, and the confidence to challenge information constructively
• Enthusiastic team player with an approachable manner and an ability to engage with colleagues across the business with a constructive and can-do attitude to deliver the successful completion of team outputs within required deadlines.

This is the pay for this position

Pay Transparency

$117,000 - $130,000 USD

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team [e-mail] to obtain prior written authorization before referring any candidates to Summit.

Summit Therapeutics Inc.is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiringprocess or thereafter. Any information that you do provide will be recorded and maintained in aconfidential file.

As set forth in Summit Therapeutics’s Equal Employment Opportunity policy,we do not discriminate on the basis of any protected group status under any applicable law.

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measurethe effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categoriesis as follows:

• A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.
• A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.
• An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.
• An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Voluntary Self-Identification of Disability

We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

• Alcohol or other substance use disorder (not currently using drugs illegally)
• Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
• Blind or low vision
• Cancer (past or present)
• Cardiovascular or heart disease
• Celiac disease
• Cerebral palsy
• Deaf or serious difficulty hearing
• Diabetes
• Disfigurement, for example, disfigurement caused by burns, wounds, accidents or congenital disorders
• Epilepsy or other seizure disorder
• Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
• Intellectual or developmental disability
• Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
• Missing limbs or partially missing limbs
• Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
• Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
• Neurodivergence, for example, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
• Partial or complete paralysis (any cause)
• Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
• Short stature (dwarfism)
• Traumatic brain injury

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.